Ascletis to Join Shanghai- and Shenzhen-Hong Kong Stock Connect, Unlocking Mainland Investor Access

Bulletin Express09-07 12:21

Ascletis Pharma Inc. announced that its ordinary shares will be added to the list of eligible securities under both the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective 7 September 2026. The decision was confirmed by recent notices from the Shanghai Stock Exchange and the Shenzhen Stock Exchange.

Under the new designation, qualified mainland Chinese investors will be able to trade Ascletis shares through domestic brokers, broadening the company’s potential investor base beyond Hong Kong. Management believes the inclusion underscores market recognition of Ascletis’s investment appeal and growth prospects, while also positioning the company for enhanced share liquidity and long-term, innovation-driven expansion.

The Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect schemes provide mutual market access between mainland China and Hong Kong by linking the respective exchanges. Ascletis’s entry into both programs places it among the Hong Kong-listed securities accessible to mainland capital.

The board of directors advises shareholders and prospective investors to exercise caution when dealing in Ascletis shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1185102831?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-07 12:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185102831","market":"hk","top_or_hot":-1,"title":"Ascletis to Join Shanghai- and Shenzhen-Hong Kong Stock Connect, Unlocking Mainland Investor Access","media":"Bulletin Express","content":"<p>Ascletis Pharma Inc. announced that its ordinary shares will be added to the list of eligible securities under both the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective 7 September 2026. The decision was confirmed by recent notices from the Shanghai Stock Exchange and the Shenzhen Stock Exchange.</p>\n<p>Under the new designation, qualified mainland Chinese investors will be able to trade Ascletis shares through domestic brokers, broadening the company’s potential investor base beyond Hong Kong. Management believes the inclusion underscores market recognition of Ascletis’s investment appeal and growth prospects, while also positioning the company for enhanced share liquidity and long-term, innovation-driven expansion.</p>\n<p>The Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect schemes provide mutual market access between mainland China and Hong Kong by linking the respective exchanges. Ascletis’s entry into both programs places it among the Hong Kong-listed securities accessible to mainland capital.</p>\n<p>The board of directors advises shareholders and prospective investors to exercise caution when dealing in Ascletis shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ascletis to Join Shanghai- and Shenzhen-Hong Kong Stock Connect, Unlocking Mainland Investor Access</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAscletis to Join Shanghai- and Shenzhen-Hong Kong Stock Connect, Unlocking Mainland Investor Access\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-07 12:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ascletis Pharma Inc. announced that its ordinary shares will be added to the list of eligible securities under both the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective 7 September 2026. The decision was confirmed by recent notices from the Shanghai Stock Exchange and the Shenzhen Stock Exchange.</p>\n<p>Under the new designation, qualified mainland Chinese investors will be able to trade Ascletis shares through domestic brokers, broadening the company’s potential investor base beyond Hong Kong. Management believes the inclusion underscores market recognition of Ascletis’s investment appeal and growth prospects, while also positioning the company for enhanced share liquidity and long-term, innovation-driven expansion.</p>\n<p>The Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect schemes provide mutual market access between mainland China and Hong Kong by linking the respective exchanges. Ascletis’s entry into both programs places it among the Hong Kong-listed securities accessible to mainland capital.</p>\n<p>The board of directors advises shareholders and prospective investors to exercise caution when dealing in Ascletis shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01672","symbol_name":"歌礼制药-B","start_time":0,"source_url":"","article_id":"1185102831","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185102831","pubTimestamp":1788754883,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Ascletis Pharma Inc. announced that its ordinary shares will be added to the list of eligible securities under both the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01672":"歌礼制药-B"},"translate_title":"歌礼将加入沪深港通，解锁内地投资者准入","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01672":1},"content_text":"Ascletis Pharma Inc. announced that its ordinary shares will be added to the list of eligible securities under both the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective 7 September 2026. The decision was confirmed by recent notices from the Shanghai Stock Exchange and the Shenzhen Stock Exchange.\nUnder the new designation, qualified mainland Chinese investors will be able to trade Ascletis shares through domestic brokers, broadening the company’s potential investor base beyond Hong Kong. Management believes the inclusion underscores market recognition of Ascletis’s investment appeal and growth prospects, while also positioning the company for enhanced share liquidity and long-term, innovation-driven expansion.\nThe Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect schemes provide mutual market access between mainland China and Hong Kong by linking the respective exchanges. Ascletis’s entry into both programs places it among the Hong Kong-listed securities accessible to mainland capital.\nThe board of directors advises shareholders and prospective investors to exercise caution when dealing in Ascletis shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1185102831","isCrawlerRequest":true}